TrialDiabetes, obesity & metabolism2016

Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine.

I Hadjiyianni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.